Abstract:Background Oridonin has been demonstrated to exert strong antitumor activities in various types of human cancers. Our previous study established that oridonin induced the apoptosis of and exerted an inhibitory effect on colon cancer cells in vitro and in vivo. However, the mechanisms behind the antitumor effects of oridonin on colorectal cancer are not clearly known. This study explored whether autophagy was involved in antitumorigenesis effects caused by the usage of oridonin in colon cancer and examined whether the AMPK/mTOR/ULK1 signaling pathway was involved in this process. Methods Cell viability was determined using CCK-8 assay. The distribution of cell apoptosis was evaluated using flow cytometry. RT-PCR and Western blotting analysis were conducted to identify the key target genes and proteins involved in the AMPK/mTOR cascade. AMPK siRNA was used to disturb AMPK expression. A DLD-1 cell orthotopic transplantation tumor model was established to explore the anti-cancer effects in vivo. Results Oridonin exhibited a suppressive effect on DLD-1 cells in a concentration- and time-dependent manner. Additionally, in a dose-dependent manner, oridonin induced cell apoptosis via inducing the protein expression levels of cleaved caspase-3, cleaved PARP and stimulated autophagy by increasing protein expression levels of Becin1, LC3-II, decreasing protein expression levels of LC3-I, p62, which were respectively attenuated and elevated by autophagy inhibitor 3-MA. Furthermore, oridonin upregulated the expression level of p-AMPK and downregulated the expression levels of p-mTOR, p-ULK1 in the DLD-1 cells in a dose-dependent manner. Moreover, knockdown of AMPK by a specific siRNA reversed the expression levels of proteins involved in the AMPK/mTOR pathway, autophagy and apoptosis. In addition, outcomes from the in vivo experiments also showed that oridonin treatment significantly repressed tumorigenic growth of DLD-1 cells without any side effects, which was accompanied by the upregulation of p-AMPK, LC3-II, active caspase-3 protein expression levels and the downregulation of p-mTOR and p-ULK1 protein expression levels. Conclusion This study demonstrated that oridonin induced apoptosis and autophagy of colon cancer DLD-1 cells via regulating the AMPK/mTOR/ULK1 pathway, which indicated that oridonin may be used as a novel therapeutic intervention for patients with colorectal cancer.

Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects

Oridonin Inhibits Bxpc-3 Cell Growth Through Cell Apoptosis

Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc

Effects of Oridonin on Proliferation of HT29 Human Colon Carcinoma Cell Lines Both in Vitro and in Vivo in Mice.

Oridonin induces apoptosis and senescence of colorectal cancer SW1116 cells in vitro and in vivo

Oridonin Induces G2/M Cell Cycle Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma.

The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo

Oridonin Inhibits Oral Cancer Growth and PI3K/Akt Signaling Pathway.

Oridonin Induces Apoptosis, Inhibits Migration and Invasion on Highly-Metastatic Human Breast Cancer Cells

Study on the mechanism for oridonin-induced apoptosis of human colon cancer cells

Oridonin Inhibits the Proliferation of Human Colon Cancer Cells by Upregulating BMP7 to Activate P38 MAPK

Oridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cells

Oridonin-induced Apoptosis in Leukemia K562 Cells and Its Mechanism.

Study on Cyclin D/Rb/p16 Signal Pathway of BxPC-3 Cell Line Treated with Oridonin

Mechanisms of Growth Inhibition and Apoptosis Inducement of Oridonin on Human Hepatic Carcinoma BEL-7402 Cells

AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells

Oridonin Enhances the Radiosensitivity of Lung Cancer Cells by Upregulating Bax and Downregulating Bcl-2

Oridonin Induced Apoptosis Through Akt and MAPKs Signaling Pathways in Human Osteosarcoma Cells.

Oridonin Induces Apoptosis of Laryngeal Carcinoma Via Endoplasmic Reticulum Stress

Oridonin Induces G2/M Cell Cycle Arrest and Apoptosis Via the PI3K/Akt Signaling Pathway in Hormone-Independent Prostate Cancer Cells.

Oridonin Inhibits the Proliferation, Migration and Invasion of Human Osteosarcoma Cells Via Suppression of Matrix Metalloproteinase Expression and STAT3 Signalling Pathway.